Clinical Trial Update: A Study to Assess the Safety and Efficacy of Different AD 237 Doses in Adults With COPD [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating multiple doses of AD 237 in adults with chronic obstructive pulmonary disease has completed, assessing safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• AD 237

Snippet

Sponsor: Sosei | Conditions: COPD | Phase 2 | Status: COMPLETED